Showing results (71-80 of 87) with videos related to
Sort By:
Pageof 9
Cancer|May 1, 1981
Chemotherapy vs. chemoimmunotherapy with methanol extraction residue of Bacillus Calmette-Guerin (MER) in advanced breast cancer: a randomized trial by the Piedmont Oncology AssociationH B Muss, F Richards, M R Cooper, et al.Cancer|June 15, 1984
Treatment of advanced non-Hodgkin's lymphoma with vincristine infusionD V Jackson, E H Paschold, C L Spurr, et al.Seminars in Oncology|March 1, 1985
Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA)H B Muss, E H Paschold, W R Black, et al.Blood|March 1, 1984
Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginaseR L Capizzi, M Poole, M R Cooper, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's diseaseR T Silver, D C Case, R H Wheeler, et al.Investigational New Drugs|January 1, 1986
Recombinant gamma interferon in advanced breast cancer: a phase II trialH B Muss, M Caponera, P J Zekan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Single agent vincristine by infusion in refractory multiple myelomaD V Jackson, L D Case, E K Pope, et al.Cancer Chemotherapy and Pharmacology|January 1, 1983
Vincristine, doxorubicin and mitomycin (VAM) in patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate and fluorouracil (CMF). A clinical trial of the Piedmont Oncology Association (POA)S K Shipp, H B Muss, M A Westrick, et al.Cancer|February 15, 1985
A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim reportJ M Sterchi, H B Wells, L D Case, et al.Cancer|June 15, 1981
A randomized comparative trial of chemotherapy and irradiation therapy for stage II breast cancerM R Cooper, A L Rhyne, H B Muss, et al.Pageof 9